Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2,4-Pyrimidinediamine, N2-1H-benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)- | 1216665-49-4 | 99.9% | 332.36 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY1753750MG

Encompass_Preferred

APY29 is an ATP-competitive inhibitor and an allosteric modulator of IRE1α. It inhibits IRE1α autophosphorylation by binding to its ATP-binding pocket with an IC50 of 280 nM. Additionally, APY29 functions as a ligand that allosterically activates the adjacent RNase domain of IRE1α.

  • ATP-competitive inhibitor of IRE1α
  • Allosteric modulator of IRE1α
  • Inhibits IRE1α autophosphorylation with an IC50 of 280 nM
  • Acts as a ligand that allosterically activates the IRE1α adjacent RNase domain
  • Divergently modulates the RNase activity and oligomerization state of IRE1α

Catalog No. 50-003-86254


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.